[TVTX] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
01-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -140.86%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 175,338 164,246 154,937 133,591 99,892 28,203 0 -
PBT -146,448 -101,867 -58,363 -57,582 105,467 -113,398 -33,748 27.69%
Tax -21 811 1,368 -9,679 -11,770 -2,460 76 -
NP -146,427 -102,678 -59,731 -47,903 117,237 -110,938 -33,824 27.64%
Tax Rate - - - - 11.16% - - -
Total Cost 321,765 266,924 214,668 181,494 -17,345 139,141 33,824 45.53%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -83.51 -62.51 -38.55 -35.86 117.36 -393.35 0.00 -
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -3.46 -2.54 -1.54 -1.29 3.49 -4.43 -2.38 6.43%
EPS Diluted -3.46 -2.54 -1.54 -1.25 3.17 -4.43 -2.38 6.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.